Business Context and Reporting Period
This Form 8-K Current Report was filed by Illumina, Inc. on October 28, 2013. The report addresses a specific corporate event under Item 8.01 (Other Events).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a notification of a corporate transaction rather than a financial performance report.
Material Changes
On October 28, 2013, Illumina, Inc. completed its previously announced acquisition of NextBio.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies related to the acquisition. It strictly confirms the completion of the transaction.
Investor Verification Checklist
- Verify the completion date of the NextBio acquisition (October 28, 2013).
- Review prior press releases or filings for the original terms and financial details of the NextBio acquisition.
- Check subsequent 10-Q or 10-K filings for the financial impact of the acquisition on Illumina's consolidated results.